Rationale of Therapeutic Plasma Exchange as Rescue Immunomodulatory Treatment for MIS-C With Multiorgan Failure

dc.contributor.author	Díaz, Franco
dc.contributor.author	Cores, Camila
dc.contributor.author	Atenas, Omar
dc.contributor.author	Rodríguez, Nicolás
dc.contributor.author	Bustos, Raúl
dc.contributor.author	Cruces, Pablo
dc.date.accessioned	2021-12-09T18:38:29Z
dc.date.available	2021-12-09T18:38:29Z
dc.date.issued	2021
dc.description.abstract	Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection is an infrequent and poorly understood illness. It can present as severe multiorgan failure in children, potentially lethal. Immunomodulation is the empiric treatment because a dysregulated immune response is the primary pathophysiologic mechanism. We present an infant with severe MIS-C, refractory to usual treatment, successfully treated with plasmapheresis.	es
dc.description.version	Versión publicada
dc.identifier.citation	Díaz F, Cores C, Atenas O, Rodríguez N, Bustos R, Cruces P. Rationale of Therapeutic Plasma Exchange as Rescue Immunomodulatory Treatment for MIS-C With Multiorgan Failure. Pediatr Infect Dis J. 2021 Jul 1;40(7):e259-e262. doi: 10.1097/INF.0000000000003169.	es
dc.identifier.uri	https://doi.org/10.1097/INF.0000000000003169	es
dc.identifier.uri	http://hdl.handle.net/11447/5212
dc.language.iso	en	es
dc.subject	MIS-C	es
dc.subject	COVID-19	es
dc.subject	Plasmapheresis	es
dc.title	Rationale of Therapeutic Plasma Exchange as Rescue Immunomodulatory Treatment for MIS-C With Multiorgan Failure	es
dc.type	Article	es
dcterms.source	Pediatric Infectious Disease Journal	es

Files

Now showing 1 - 1 of 1

Name:: Pediatric Infectious Disease Journal_2021_Díaz_Rationale of Therapeutic Plasma Exchange as Rescue Immunomodulatory Treatment for MIS-C With Multiorgan Failure.pdf
Size:: 406.4 KB
Format:: Adobe Portable Document Format
Description:: Texto completo restringido

Now showing 1 - 1 of 1